Trial Profile
A Study of Bitopertin (RO4917838) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Roche
- 12 Jul 2012 New source identified and integrated (ClinicalTrials.gov record NCT01636492).
- 19 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 19 Apr 2012 New trial record